ducovest

CTRE:NYE-CareTrust REIT Inc. (USD)

COMMON STOCK | REIT - Healthcare Facilities |

Last Closing

USD 25.87

Change

0.00 (0.00)%

Market Cap

USD 4.68B

Volume

4.76M

Analyst Target

USD 18.67
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

CareTrust REIT, Inc.'s ("CareTrust REIT" or the "Company") primary business consists of acquiring, financing, developing and owning real property to be leased to third-party tenants in the healthcare sector. As of March 31, 2024, the Company owned directly or through a joint venture and leased to independent operators, 228 skilled nursing facilities ("SNFs"), multi-service campuses, assisted living facilities ("ALFs") and independent living facilities ("ILFs") consisting of 24,189 operational beds and units located in 29 states with the highest concentration of properties by rental income located in California and Texas. As of March 31, 2024, the Company also had other real estate related investments consisting of one preferred equity investment, nine real estate secured loans receivable and four mezzanine loans receivable with a carrying value of $233.3 million.

Company Website : https://www.caretrustreit.com

Currency: USD

Country : USA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-02 )

Largest Industry Peers for REIT - Healthcare Facilities

Symbol Name Price(Change) Market Cap
WELL Welltower Inc

N/A

 USD 88.79B
VTR Ventas Inc

N/A

 USD 29.08B
DOC Healthpeak Properties Inc

N/A

 USD 13.70B
AHR American Healthcare REIT, Inc.

N/A

 USD 4.18B
NHI National Health Investors Inc

N/A

 USD 3.08B
LTC LTC Properties Inc

N/A

 USD 1.54B
CHCT Community Healthcare Trust Inc

N/A

 USD 0.56B
UHT Universal Health Realty Income..

N/A

 USD 0.54B
GMRE-PA Global Medical REIT Inc

N/A

 USD 0.41B
OHI Omega Healthcare Investors Inc

N/A

 N/A

ETFs Containing CTRE

UTES Virtus Reaves Utilities E.. 5.08 % 0.95 %

N/A

 USD 0.42B
CINF:CA CI Global Infrastructure .. 4.66 % 0.00 %

N/A

 CAD 0.27B
DXN:CA Dynamic Active Global Inf.. 4.16 % 0.00 %

N/A

 CAD 0.03B
INFR ClearBridge Sustainable I.. 3.62 % 0.47 %

N/A

 USD 9.00M
HDLV 3.31 % 0.00 %

N/A

 N/A
FOVL iShares Focused Value Fac.. 3.08 % 0.25 %

N/A

 USD 0.03B
XLUY 3.00 % 0.00 %

N/A

 N/A
HDLV:PA Invesco S&P 500 High Divi.. 2.51 % 0.00 %

N/A

 USD 0.34B
HDLV:F Invesco S&P 500 High Divi.. 2.51 % 0.00 %

N/A

 N/A
HDLV:XETRA Invesco S&P 500 High Divi.. 2.51 % 0.00 %

N/A

 N/A
CZA Invesco Zacks Mid-Cap ETF 2.36 % 0.65 %

N/A

 N/A
DVY iShares Select Dividend E.. 1.92 % 0.39 %

N/A

 N/A
DJXXF 1.92 % 0.00 %

N/A

 N/A
EXX5:F iShares Dow Jones U.S. Se.. 1.81 % 0.00 %

N/A

 N/A
EXX5:XETRA iShares Dow Jones U.S. Se.. 1.81 % 0.00 %

N/A

 USD 0.37B
CDL VictoryShares US Large Ca.. 1.66 % 0.35 %

N/A

 USD 0.36B
TPHE Timothy Plan - Timothy Pl.. 1.64 % 0.00 %

N/A

 USD 0.06B
CDC VictoryShares US EQ Incom.. 1.63 % 0.35 %

N/A

 USD 0.79B
TPHD Timothy Plan High Dividen.. 1.63 % 0.00 %

N/A

 USD 0.24B
DIVA 1.07 % 1.00 %

N/A

 N/A
ULOV:LSE 0.72 % 0.00 %

N/A

 N/A
TPLE Timothy Plan - Timothy Pl.. 0.69 % 0.00 %

N/A

 USD 0.07B
TPLC Timothy Plan US Large/Mid.. 0.65 % 0.00 %

N/A

 USD 0.26B
BTAL AGFiQ U.S. Market Neutral.. 0.49 % 0.00 %

N/A

 N/A
JPME JPMorgan Diversified Retu.. 0.48 % 0.24 %

N/A

 USD 0.41B
JHMM John Hancock Multifactor .. 0.47 % 0.44 %

N/A

 USD 4.20B
JPUS JPMorgan Diversified Retu.. 0.46 % 0.19 %

N/A

 USD 0.44B
CFA VictoryShares US 500 Vola.. 0.37 % 0.35 %

N/A

 USD 0.54B
FVD First Trust Value Line® .. 0.00 % 0.70 %

N/A

 N/A
PSCF Invesco S&P SmallCap Fina.. 0.00 % 0.29 %

N/A

 USD 0.02B
USVM VictoryShares US Small Mi.. 0.00 % 0.25 %

N/A

 USD 0.89B
FTGU:F First Trust Global Funds .. 0.00 % 0.00 %

N/A

 N/A
XU61:XETRA BNP Paribas EASY ECPI Glo.. 0.00 % 0.00 %

N/A

 N/A
JPGL:XETRA JPM Global Equity Multi-F.. 0.00 % 0.00 %

N/A

 N/A
HSMV First Trust Horizon Manag.. 0.00 % 0.00 %

N/A

 USD 0.02B
JPGL:F JPmorgan ETFs Ireland Ica.. 0.00 % 0.00 %

N/A

 N/A

Market Performance

  Market Performance vs. Industry/Classification (REIT - Healthcare Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -4.36% 7% C- 19% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -4.36% 7% C- 19% F
Trailing 12 Months  
Capital Gain 13.46% 43% F 73% C
Dividend Return 6.36% 43% F 80% B-
Total Return 19.82% 43% F 79% B-
Trailing 5 Years  
Capital Gain 18.67% 85% B 52% F
Dividend Return 26.28% 62% D 74% C
Total Return 44.95% 77% C+ 56% F
Average Annual (5 Year Horizon)  
Capital Gain 11.56% 79% B- 68% D+
Dividend Return 16.89% 86% B+ 75% C
Total Return 5.34% 50% F 84% B
Risk Return Profile  
Volatility (Standard Deviation) 22.75% 57% F 48% F
Risk Adjusted Return 74.26% 86% B+ 83% B
Market Capitalization 4.68B 70% C- 77% C+

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.